Maarten W Nijsten
Overview
Explore the profile of Maarten W Nijsten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Leeuwen O, Lantinga V, Lascaris B, Thorne A, Bodewes S, Nijsten M, et al.
Nat Protoc
. 2025 Feb;
PMID: 40011689
The shortage of suitable donor organs has resulted in the use of suboptimal, high-risk, extended-criteria donor (ECD) livers, which are at an increased risk of failure after transplantation. Compared with...
2.
Zijlstra H, Westland G, Volbeda M, van Meurs M, Pillay J, Franssen C, et al.
Sci Rep
. 2024 Oct;
14(1):25779.
PMID: 39468058
Whereas urinary creatinine excretion (UCE) is an established marker of muscle mass, both in critically ill and non-critically ill patients, analysis of urinary urea excretion (UUE) may allow estimation of...
3.
Creatinine clearance/eGFR ratio: a simple index for muscle mass related to mortality in ICU patients
Volbeda M, Zijlstra H, Post A, Kootstra-Ros J, van der Voort P, Franssen C, et al.
BMC Nephrol
. 2024 Oct;
25(1):330.
PMID: 39358684
Introduction: In patients admitted to the intensive care unit (ICU), muscle mass is inversely associated with mortality. Although muscle mass can be estimated with 24-h urinary creatinine excretion (UCE), its...
4.
Posma R, Bakker S, Nijsten M, Touw D, Tsikas D
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999257
Metformin is the most widely used drug in type 2 diabetes. Regular metformin use has been associated with changes in concentrations of amino acids. In the present study, we used...
5.
Baskal S, Posma R, Bollenbach A, Dieperink W, Bakker S, Nijsten M, et al.
Amino Acids
. 2024 Mar;
56(1):21.
PMID: 38461423
Metformin (N,N-dimethylbiguanide), an inhibitor of gluconeogenesis and insulin sensitizer, is widely used for the treatment of type 2 diabetes. In some patients with renal insufficiency, metformin can accumulate and cause...
6.
Shajiei A, Berends M, Luz C, van Oers J, Harmsen H, Vos P, et al.
Front Med (Lausanne)
. 2023 Feb;
10:1080007.
PMID: 36817782
Background: In the previously reported SAPS trial (https://clinicaltrials.gov/ct2/show/NCT01139489), procalcitonin-guidance safely reduced the duration of antibiotic treatment in critically ill patients. We assessed the impact of shorter antibiotic treatment on antimicrobial...
7.
Freire Jorge P, Goodwin M, Renes M, Nijsten M, Pamenter M
Front Physiol
. 2022 May;
13:859820.
PMID: 35600297
Metabolic flexibility in mammals enables stressed tissues to generate additional ATP by converting large amounts of glucose into lactic acid; however, this process can cause transient local or systemic acidosis....
8.
de Jong W, El Moumni M, Wendt K, Nijsten M, Hulscher J
Br J Surg
. 2022 May;
109(9):796-799.
PMID: 35583155
No abstract available.
9.
van der Meer S, Figaroa G, van der Voort P, Nijsten M, Pillay J
Crit Care
. 2021 Dec;
25(1):445.
PMID: 34930419
No abstract available.
10.
Multi-infusion with integrated multiple pressure sensing allows earlier detection of line occlusions
Doesburg F, Oelen R, Renes M, Lourenco P, Touw D, Nijsten M
BMC Med Inform Decis Mak
. 2021 Oct;
21(1):295.
PMID: 34711186
Background: Occlusions of intravenous (IV) tubing can prevent vital and time-critical medication or solutions from being delivered into the bloodstream of patients receiving IV therapy. At low flow rates (≤ ...